These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6339205)

  • 1. Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Tatemoto K; Efendić S
    Endocrinology; 1983 Apr; 112(4):1469-73. PubMed ID: 6339205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Efendić S
    Endocrinology; 1982 Apr; 110(4):1268-72. PubMed ID: 7037370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas.
    Szecówka J; Sandberg E; Efendić S
    Diabetologia; 1980 Aug; 19(2):137-42. PubMed ID: 6106616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat.
    Nilsson SF; Mäepea O
    Acta Physiol Scand; 1987 Jan; 129(1):17-26. PubMed ID: 3565040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets.
    Bailey CJ; Wilkes LC; Conlon JM; Armstrong PH; Buchanan KD
    J Endocrinol; 1990 Jun; 125(3):375-9. PubMed ID: 1973701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vasoactive intestinal polypeptide infused intrapancreatically on glucagon and insulin secretion.
    Kaneto A; Kaneko T; Kajinuma H; Kosaka K
    Metabolism; 1977 Jul; 26(7):781-6. PubMed ID: 865285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory effects of VIP on isolated perfused porcine pancreas.
    Jensen SL; Fahrenkrug J; Holst JJ; Nielsen OV; Schaffalitzky de Muckadell OB
    Am J Physiol; 1978 Oct; 235(4):E387-91. PubMed ID: 696859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PYY and PP on endocrine pancreas.
    Szecówka J; Tatemoto K; Rajamäki G; Efendić S
    Acta Physiol Scand; 1983; 119(2):123-6. PubMed ID: 6362333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide.
    Schebalin M; Said SI; Makhlouf GM
    Am J Physiol; 1977 Feb; 232(2):E197-200. PubMed ID: 320878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin-releasing activity of porcine intestinal peptide (PHI-27).
    Samson WK; Lumpkin MD; McDonald JK; McCann SM
    Peptides; 1983; 4(6):817-9. PubMed ID: 6689504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and glucagon secretion in the rat: effects of gastrin releasing peptide.
    Pettersson M; Ahrén B
    Neuropeptides; 1988 Oct; 12(3):159-63. PubMed ID: 3071743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
    Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T
    Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin action on insulin secretion induced by chicken and porcine vasoactive intestinal peptide in the perfused rat pancreas.
    Arilla E; Prieto JC; López-Martínez JM; Goberna R
    Horm Metab Res; 1981 Jun; 13(6):314-7. PubMed ID: 6114916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretin, VIP, and PHI stimulate rat proximal duodenal surface epithelial bicarbonate secretion in vivo.
    Isenberg JI; Wallin B; Johansson C; Smedfors B; Mutt V; Tatemoto K; Emas S
    Regul Pept; 1984 Jul; 8(4):315-20. PubMed ID: 6548570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of peptide HI on basal and stimulated insulin and glucagon secretion in the mouse.
    Ahrén B; Lundquist I
    Neuropeptides; 1988; 11(4):159-62. PubMed ID: 3047591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of galanin on islet cell secretory responses to VIP, GIP, 8-CCK, and glucagon by the perfused rat pancreas.
    Miralles P; Peiró E; Silvestre RA; Villanueva ML; Marco J
    Metabolism; 1988 Aug; 37(8):766-70. PubMed ID: 2457142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebroventricular infusion of neuropeptide Y modulates VIP secretion in the fasting conscious dog.
    Anastasiou OE; Yavropoulou MP; Kesisoglou I; Kotsa K; Yovos JG
    Neuropeptides; 2009 Feb; 43(1):41-6. PubMed ID: 19058848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes.
    Taton G; Chatelain P; Delhaye M; Camus JC; De Neef P; Waelbroeck M; Tatemoto K; Robberecht P; Christophe J
    Peptides; 1982; 3(6):897-900. PubMed ID: 6897744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of helospectin I on insulin and glucagon secretion in the mouse.
    Ahrén B
    Br J Pharmacol; 1991 Apr; 102(4):916-8. PubMed ID: 1855119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.